Treatment of Dogs with Fluralaner Reduced Pyrethroid-resistant Triatoma Infestans abundance, Trypanosoma Cruzi Infection and Human-triatomine contact in the Argentine Chaco
Overview
Tropical Medicine
Authors
Affiliations
Background: Triatomine elimination efforts and the interruption of domestic transmission of Trypanosoma cruzi are hampered by pyrethroid resistance. Fluralaner, a long-lasting ectoparasiticide administered to dogs, substantially reduced site infestation and abundance of pyrethroid-resistant Triatoma infestans Klug (Heteroptera: Reduviidae) in an ongoing 10-month trial in Castelli (Chaco Province, Argentina). We assessed the effects of fluralaner on vector infection with T. cruzi and blood meal sources stratified by ecotope and quantified its medium-term effects on site infestation and triatomine abundance.
Methods: We conducted a placebo-controlled, before-and-after efficacy trial of fluralaner in 28 infested sites over a 22-month period. All dogs received either an oral dose of fluralaner (treated group) or placebo (control group) at 0 month post-treatment [MPT]. Placebo-treated dogs were rescue-treated with fluralaner at 1 MPT, as were all eligible dogs at 7 MPT. Site-level infestation and abundance were periodically assessed by timed manual searches with a dislodging aerosol. Vector infection was mainly determined by kDNA-PCR and blood meal sources were determined by enzyme-linked immunosorbent assay.
Results: In fluralaner-treated households, site infestation dropped from 100% at 0 MPT to 18-19% over the period 6-22 MPT while mean abundance plummeted from 5.5 to 0.6 triatomines per unit effort. In control households, infestation dropped similarly post-treatment. The overall prevalence of T. cruzi infection steadily decreased from 13.8% at 0-1 MPT (baseline) to 6.4% and subsequently 2.3% thereafter, while in domiciles, kitchens and storerooms it dropped from 17.4% to 4.7% and subsequently 3.3% thereafter. Most infected triatomines occurred in domiciles and had fed on humans. Infected-bug abundance plummeted after fluralaner treatment and remained marginal or nil thereafter. The human blood index of triatomines collected in domiciles, kitchens and storerooms highly significantly fell from 42.9% at baseline to 5.3-9.1% over the period 6-10 MPT, increasing to 36.8% at 22 MPT. Dog blood meals occurred before fluralaner administration only. The cat blood index increased from 9.9% at baseline to 57.9-72.7% over the period 6-10 MPT and dropped to 5.3% at 22 MPT, whereas chicken blood meals rose from 39.6% to 63.2-88.6%.
Conclusion: Fluralaner severely impacted infestation- and transmission-related indices over nearly 2 years, causing evident effects at 1 MPT, and deserves larger efficacy trials.
Cecere M, Gaspe M, Macchiaverna N, Enriquez G, Alvedro A, Laino M Parasit Vectors. 2024; 17(1):287.
PMID: 38956689 PMC: 11220979. DOI: 10.1186/s13071-024-06366-7.
Pereira L, Pereira N, da Silva A, Bezerra C, Sousa K, Fagundes Neto J Parasit Vectors. 2024; 17(1):208.
PMID: 38720313 PMC: 11080163. DOI: 10.1186/s13071-024-06276-8.
Busselman R, Zecca I, Hamer G, Hamer S Am J Trop Med Hyg. 2023; 109(5):1012-1021.
PMID: 37748769 PMC: 10622482. DOI: 10.4269/ajtmh.23-0300.
Gurtler R, Enriquez G, Gaspe M, Macchiaverna N, Pilar Fernandez M, Rodriguez-Planes L Parasit Vectors. 2023; 16(1):258.
PMID: 37528423 PMC: 10394798. DOI: 10.1186/s13071-023-05861-7.
Durden C, Tian Y, Knape K, Klemashevich C, Norman K, Carey J Parasit Vectors. 2023; 16(1):178.
PMID: 37268980 PMC: 10236763. DOI: 10.1186/s13071-023-05805-1.